New drugs are being reported to offer hope for the treatment of pancreatic cancer, with some outlets suggesting they may improve survival rates. At least one of the drugs is said to have shown survival gains in trials, and another is mentioned as having the potential to double survival time. The development of these drugs is being covered by multiple outlets, with some highlighting the potential for breakthrough treatments.